3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Neoplasms
2
Melanoma
2
Hematologic Neoplasms
2
Febrile Neutropenia
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neutropenia
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Liver Neoplasms
1
Hematologic Diseases
1
Early Stage Non-Small Cell Lung Cancer
1
Clostridium Infections
1
Breast Neoplasms
1
Interventions
Rituximab
7
Vemurafenib
4
Cyclophosphamide
4
Cladribine
4
Specimen Handling
3
Biopsy
3
obinutuzumab
2
ibrutinib
2
fludarabine phosphate
2
fludarabine
2
binimetinib
2
Diphenhydramine
2
Dexamethasone
2
Calcium Dobesilate
2
CT-P10
2
Acetaminophen
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
immunotoxin HA22
1
encorafenib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brexucabtagene autoleucel
1
auricularum
1
acalabrutinib
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Vancomycin
×
1 year
×
Clear all
No trials found.